{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:58:38Z","timestamp":1790823518489,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1124\/jpet.118.254201","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T15:57:37Z","timestamp":1554911857000},"page":"481-488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Apolipoprotein A-I Crosses the Blood-Brain Barrier through Clathrin-Independent and Cholesterol-Mediated Endocytosis"],"prefix":"10.1016","volume":"369","author":[{"given":"Andrew L","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh K","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffry L","family":"Curran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F","family":"Poduslo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val J","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karunya K","family":"Kandimalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.118.254201_bib1","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1021\/mp300352c","article-title":"Traffic jam at the blood-brain barrier promotes greater accumulation of Alzheimer\u2019s disease amyloid-\u03b2 proteins in the cerebral vasculature","volume":"10","author":"Agyare","year":"2013","journal-title":"Mol Pharm"},{"issue":"23","key":"10.1124\/jpet.118.254201_bib2","first-page":"III8","article-title":"HDL cholesterol and protective factors in atherosclerosis","volume":"109","author":"Assmann","year":"2004","journal-title":"Circulation"},{"key":"10.1124\/jpet.118.254201_bib3","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1471-4159.2004.02373.x","article-title":"Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier model","volume":"89","author":"Balazs","year":"2004","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.118.254201_bib4","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1016\/j.yexcr.2006.09.025","article-title":"Role of lipids and actin in the formation of clathrin-coated pits","volume":"312","author":"Boucrot","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1124\/jpet.118.254201_bib5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.pneurobio.2008.12.002","article-title":"Delivery of peptide and protein drugs over the blood-brain barrier","volume":"87","author":"Brasnjevic","year":"2009","journal-title":"Prog Neurobiol"},{"key":"10.1124\/jpet.118.254201_bib6","first-page":"7","article-title":"Half life of injected 125I-insulin in control and ob\/ob mice","volume":"27","author":"Cresto","year":"1977","journal-title":"Acta Physiol Lat Am"},{"key":"10.1124\/jpet.118.254201_bib7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2217\/clp.10.37","article-title":"Apolipoproteins in the brain: implications for neurological and psychiatric disorders","volume":"51","author":"Elliott","year":"2010","journal-title":"Clin Lipidol"},{"key":"10.1124\/jpet.118.254201_bib8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3389\/fphys.2017.00841","article-title":"SR-BI mediated transcytosis of HDL in brain microvascular endothelial cells is independent of caveolin, clathrin, and PDZK1","volume":"8","author":"Fung","year":"2017","journal-title":"Front Physiol"},{"key":"10.1124\/jpet.118.254201_bib9","doi-asserted-by":"crossref","first-page":"20646","DOI":"10.1038\/srep20646","article-title":"Scavenger receptor B1, the HDL receptor, is expressed abundantly in liver sinusoidal endothelial cells","volume":"6","author":"Ganesan","year":"2016","journal-title":"Sci Rep"},{"issue":"Pt A","key":"10.1124\/jpet.118.254201_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nbd.2014.07.015","article-title":"HDL and cognition in neurodegenerative disorders","volume":"72","author":"Hottman","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.1124\/jpet.118.254201_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1074\/jbc.M110.168468","article-title":"The essential role of clathrin-mediated endocytosis in the infectious entry of human enterovirus 71","volume":"286","author":"Hussain","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.118.254201_bib12","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1124\/jpet.104.081901","article-title":"Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer\u2019s disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation","volume":"313","author":"Kandimalla","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.254201_bib13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.dadm.2017.01.007","article-title":"Apolipoproteins and their subspecies in human cerebrospinal fluid and plasma","volume":"6","author":"Koch","year":"2017","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1124\/jpet.118.254201_bib14","doi-asserted-by":"crossref","first-page":"36945","DOI":"10.1074\/jbc.M110.127738","article-title":"Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP\/PS1\u0394E9 mice","volume":"285","author":"Lefterov","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.118.254201_bib15","doi-asserted-by":"crossref","first-page":"36958","DOI":"10.1074\/jbc.M110.127829","article-title":"Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease","volume":"285","author":"Lewis","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.118.254201_bib16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbagen.2011.09.009","article-title":"The intracellular trafficking pathway of transferrin","volume":"1820","author":"Mayle","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.118.254201_bib17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm3151","article-title":"Molecular mechanism and physiological functions of clathrin-mediated endocytosis","volume":"12","author":"McMahon","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1124\/jpet.118.254201_bib18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3233\/JAD-150976","article-title":"Modulation of amyloid-\u03b21-40 transport by ApoA1 and ApoJ across an in vitro model of the blood-brain barrier","volume":"53","author":"Merino-Zamorano","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1124\/jpet.118.254201_bib19","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1073\/pnas.89.6.2218","article-title":"Increased permeability across the blood-nerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy","volume":"89","author":"Poduslo","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.118.254201_bib20","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1073\/pnas.91.12.5705","article-title":"Macromolecular permeability across the blood-nerve and blood-brain barriers","volume":"91","author":"Poduslo","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.118.254201_bib21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1006\/nbdi.2001.0402","article-title":"Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer\u2019s disease","volume":"8","author":"Poduslo","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1124\/jpet.118.254201_bib22","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1073\/pnas.76.9.4646","article-title":"Apolipoproteins in human cerebrospinal fluid","volume":"76","author":"Roheim","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.118.254201_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-2275(20)37012-7","article-title":"Measurement of apolipoprotein A-I in rat high density lipoprotein and in rat plasma by radioimmunoassay","volume":"17","author":"Schonfeld","year":"1976","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.118.254201_bib24","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1471-4159.1986.tb08491.x","article-title":"Cerebrovascular permeability coefficients to sodium, potassium, and chloride","volume":"46","author":"Smith","year":"1986","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.118.254201_bib25","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1021\/mp300518e","article-title":"Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules","volume":"10","author":"Strazielle","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.118.254201_bib26","doi-asserted-by":"crossref","first-page":"e001156","DOI":"10.1161\/JAHA.114.001156","article-title":"Intravenously injected human apolipoprotein A-I rapidly enters the central nervous system via the choroid plexus","volume":"3","author":"Stukas","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1124\/jpet.118.254201_bib27","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cmet.2014.01.003","article-title":"High-density lipoproteins and cerebrovascular integrity in Alzheimer\u2019s disease","volume":"19","author":"Stukas","year":"2014","journal-title":"Cell Metab"},{"key":"10.1124\/jpet.118.254201_bib28","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/0271678X17709709","article-title":"Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain","volume":"38","author":"Swaminathan","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1124\/jpet.118.254201_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2045-8118-10-16","article-title":"The hCMEC\/D3 cell line as a model of the human blood brain barrier","volume":"10","author":"Weksler","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1124\/jpet.118.254201_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/alzrt6","article-title":"Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease","volume":"1","author":"Weller","year":"2009","journal-title":"Alzheimers Res Ther"},{"key":"10.1124\/jpet.118.254201_bib31","doi-asserted-by":"crossref","first-page":"703545","DOI":"10.1155\/2013\/703545","article-title":"Receptor-mediated endocytosis and brain delivery of therapeutic biologics","volume":"2013","author":"Xiao","year":"2013","journal-title":"Int J Cell Biol"},{"key":"10.1124\/jpet.118.254201_bib32","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.bbamem.2007.03.026","article-title":"Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies","volume":"1768","author":"Zidovetzki","year":"2007","journal-title":"Biochim Biophys Acta"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524260043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524260043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.118.254201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:00:43Z","timestamp":1739962843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524260043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0022356524260043"],"URL":"https:\/\/doi.org\/10.1124\/jpet.118.254201","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apolipoprotein A-I Crosses the Blood-Brain Barrier through Clathrin-Independent and Cholesterol-Mediated Endocytosis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.118.254201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}